Location: Home
  • search
  • go
  • Relate News
  • 2/7/2025AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
  • 2/7/2025NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
  • 2/7/2025Henlius Biotech's Lung Cancer Drug Secures EU Approval
  • 2/7/2025Toll Biotech Secures FDA and NMPA IND Approvals for TLR8 Modulator Tol...
  • 2/7/2025Henlius and Dr. Reddy's Ink Licensing Deal for Daratumumab Biosimilar ...
  • 2/7/2025Recent Executive Moves
  • 2/7/2025Chinese Biotech Firms Cash In On Promising Drug Discoveries Via Licens...
  • 2/7/2025Rapid Trials Prompt Deals Rush for Chinese ‘Super Me-Too’ Drugs (FT)
  • 2/7/2025China's Biopharma Mirrors EV Success (The China Academy)
  • 2/6/2025Merck Halts HPV Vaccine Supply: What It Says about China Market (EGGI)
  • 2/6/2025DeepSeek Signals China's Rising Influence in AI — and AI Drug Develop...
  • 2/6/2025GSK Faces Vaccine Challenges in China Amid Market Pressures
  • 2/6/2025Roche Reports Strong 2024 Growth with China Sales Reaching $6.1 Billio...
  • 2/5/2025NH Reports Latest Data on Chinese Smoking Control Market in MAT 09/202...
  • 2/5/2025NH Reports on Booming Chinese Sedatives and Sleep Aids Market in MAT 0...
  • 2/5/2025NH Reports Latest Data on the Chinese Eye Care Market in MAT 09/2024
  • 2/5/2025MediLink's YL217 received FDA Clearance of IND Application
  • 2/5/2025Merck Faces Growing Challenges in China as Gardasil Sales Stall  
  • 2/5/2025 Pfizer Eyes Expansion in China Amid Pipeline Reshuffle
  • 2/5/2025China Next: Tariffs War and Its Ripple Effect (EGGI)
  • 2/5/2025Trump's Tariffs Threaten Big Pharma With Higher Costs and Slimmer Marg...
  • 2/2/2025China Tightens the Reins: Anti-Corruption Compliance Expectations for ...
  • 2/2/2025I-Mab Cuts 27% of Workforce Amid Strategic Shift
  • 2/2/2025FDA Approves XellSmart's IND for iPSC-Derived Cell Therapy in Parkinso...
  • 2/2/2025BeiGene Launches Phase 1 Trial for CLDN6/CD3 BsAb BGB-B455 in Solid Tu...
  • 2/2/2025FDA Approves Minwei Biotech's IND for MWN105
  • 2/2/2025ImmunityBio and BeiGene Partner on Phase 3 Trial of ANKTIVA and PD-1 I...
  • 2/2/2025Vigonvita Life Sciences Submits IPO Application to Hong Kong Stock Exc...
  • 1/28/2025CStone Partners with SteinCares to Market Sugemalimab in Latin America
  • 1/28/2025InnoCare's Efsubaglutide Alfa Receives Approval in China for Type 2 Di...
  • Page:15/764 Total number of articles:22906: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group